Suministro de Medicamento Ublituximab 150 mg vial (BRIUMVI) de distribución exclusiva del Laboratorio Neuraxpharm Spain S.L con destino al Servicio de Farmacia del Hospital Clínico San Carlos
TED · 323886-2026Award noticeawardedNo deadline given
Value
Estimated€391,541 · 391,540.51 EUR
Awarded€177,973 · 177,972.96 EUR
WinnerLABORATORIO NEURAXPHARM SPAIN S.L.
Who already wins at this buyer
Firms with recorded awards from HOSPITAL CLINICO SAN CARLOS in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| GILEAD SCIENCES, S.L. | 3 | €774,418 | 2026-07-27 |
| Novocure Spain, S.L. | 3 | €729,216 | 2026-05-27 |
| Medtronic Ibérica, S.A. | 2 | €340,313 | 2026-05-29 |
| W.L.GORE Y ASOCIADOS, S.L. | 1 | €531,794 | 2026-05-29 |
| ROCHE FARMA, S.A.U. | 1 | €526,876 | 2026-05-05 |
Full buyer profile: what HOSPITAL CLINICO SAN CARLOS buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Suministro de Medicamento Ublituximab 150 mg vial (BRIUMVI) de distribución exclusiva del Laboratorio Neuraxpharm Spain S.L con destino al Servicio de Farmacia del Hospital Clínico San Carlos
Similar tenders
Closest by meaning — across languages, via embeddings.